US2010239636A1PendingUtilityA1
Methods and Devices for Delivering Therapeutic Agents to Target Vessels
Est. expiryApr 18, 2017(expired)· nominal 20-yr term from priority
A61F 2/91A61F 2002/91541A61L 31/16A61F 2002/91558A61P 9/00A61L 2300/416A61L 31/10A61F 2250/0068A61F 2/915A61L 2300/606A61F 2250/0067
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of preparing devices for delivering at least one therapeutic agent to a target vessel in a mammal, the devices prepared by such methods, and uses of such devices for delivering a therapeutic agent, such as an antiproliferative agent, to a target vessel.
Claims
exact text as granted — not AI-modified1 . A perivascular wrap comprising a polymer and an antiproliferative drug, wherein said wrap forms a flexible sheet having a thickness of about 10 μm to about 1000 μm.
2 . The perivascular wrap according to claim 1 comprising about 0.001 weight percent to about 30 weight percent of said antiproliferative drug.
3 . The perivascular wrap according to claim 1 wherein said antiproliferative drug comprises rapamycin or a macrocyclic lactone analog thereof.
4 . The perivascular wrap according to claim 1 wherein said polymer is degradable.
5 . The perivascular wrap according to claim 1 wherein said polymer is non-degradable.
6 . A perivascular coating composition in the form of a flexible sheet, said sheet comprising a polymer and a therapeutic agent, wherein said polymer has a melting temperature of above 37° C.
7 . The perivascular coating composition according to claim 6 wherein said polymer has a melting temperature of about of 40° C.-45° C.
8 . The perivascular coating composition according to claim 6 wherein said polymer is degradable.
9 . The perivascular coating composition according to claim 6 wherein said polymer is non-degradable.
10 . The perivascular coating composition according to claim 6 wherein said therapeutic agent comprises rapamycin or a macrocyclic lactone analog thereof.Join the waitlist — get patent alerts
Track US2010239636A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.